相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
Jeremiah L. Oyer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
Gianfranco Pittari et al.
FRONTIERS IN IMMUNOLOGY (2015)
Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients
Nadia Peragine et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
Inpyo Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Expansion and Homing of Adoptively Transferred Human Natural Killer Cells in Immunodeficient Mice Varies with Product Preparation and In Vivo Cytokine Administration: Implications for Clinical Therapy
Jeffrey S. Miller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
Lena Oevermann et al.
BLOOD (2014)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Effect of exposure to interleukin-21 at various time points on human natural killer cell culture
Dong-Pyo Lim et al.
CYTOTHERAPY (2014)
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells
Giovanni F. Torelli et al.
HAEMATOLOGICA (2014)
Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
Sarah Cooley et al.
JOURNAL OF IMMUNOLOGY (2014)
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
J. Chu et al.
LEUKEMIA (2014)
Donor Activating KIR2DS1 in Leukemia
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis
Fu-Nan Cho et al.
PLOS ONE (2014)
Natural killer cells in the treatment of high-risk acute leukaemia
Franco Locatelli et al.
SEMINARS IN IMMUNOLOGY (2014)
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M. Stern et al.
BONE MARROW TRANSPLANTATION (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Irradiated and Activated Autologous PBMCs Induce Expansion of Highly Cytotoxic Human NK Cells In Vitro
Yong-Oon Ahn et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol
Ulrike Koehl et al.
FRONTIERS IN ONCOLOGY (2013)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
D-F Chen et al.
BONE MARROW TRANSPLANTATION (2012)
A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
Noriko Shimasaki et al.
CYTOTHERAPY (2012)
Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
Michelle K. Gleason et al.
MOLECULAR CANCER THERAPEUTICS (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
Lorenzo Moretta et al.
BLOOD (2011)
Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT
Simona Sivori et al.
BLOOD (2011)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
Andreas Lundqvist et al.
JOURNAL OF CANCER (2011)
Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
S. R. Yoon et al.
BONE MARROW TRANSPLANTATION (2010)
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
Uwe Siegler et al.
CYTOTHERAPY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Daniela Pende et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?
Jeffrey S. Miller
CYTOTHERAPY (2009)
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Maria Berg et al.
CYTOTHERAPY (2009)
Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation
Sandrine Meyer-Monard et al.
TRANSFUSION (2009)
Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells
Laurent Boissel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Promiscuity and the single receptor: NKG2D
Robert A. Eagle et al.
NATURE REVIEWS IMMUNOLOGY (2007)
KIR2DS1-positive NK cells mediate alloresponse against the C2HLA-KIR ligand group in vitro
Joseph H. Chewning et al.
JOURNAL OF IMMUNOLOGY (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience
D. H. McKenna et al.
TRANSFUSION (2007)
Human natural killer cell development
Aharon G. Freud et al.
IMMUNOLOGICAL REVIEWS (2006)
The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance
Anja Fuchs et al.
SEMINARS IN CANCER BIOLOGY (2006)
The role of the NKG2D receptor for tumor immunity
Jerome D. Coudert et al.
SEMINARS IN CANCER BIOLOGY (2006)
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors
CA Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Natural killer cell signaling pathways
E Vivier et al.
SCIENCE (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Large-scale generation of natural killer lymphocytes for clinical application
J Luhm et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Clinical scale isolation of T cell-depleted CD56(+) donor lymphocytes in children
P Lang et al.
BONE MARROW TRANSPLANTATION (2002)
A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells
S Carlens et al.
HUMAN IMMUNOLOGY (2001)
The biology of natural killer cells in cancer, infection, and pregnancy
JS Miller
EXPERIMENTAL HEMATOLOGY (2001)
分享论文
